Health News

Jul 2, 2025

A new AI tool predicts type 1 diabetes risk

Scientists created an AI-powered risk score using microRNAs to better predict who might develop type 1 diabetes, helping doctors personalize care and avoid misdiagnosis.

Imagine if doctors could know who might develop type 1 diabetes before it even happens, and help prevent problems before they start. Thanks to a clever new tool that uses artificial intelligence (AI) and special molecules called microRNAs, this is becoming possible. In a big study that looked at almost 6,000 people from seven different countries, scientists created a new way to check someone’s risk for type 1 diabetes over time, not just once. This could make a big difference for kids and adults everywhere who are worried about their health.

Understanding type 1 diabetes and why prediction matters

Type 1 diabetes (T1D) happens when the body’s immune system attacks the cells that make insulin, a hormone that helps control blood sugar. Unlike type 2 diabetes, which is often linked to lifestyle, T1D can develop in children or adults and is mostly caused by a mix of genes and other triggers. Predicting who is likely to get T1D is tough because the risk changes over time and depends on many factors. Sometimes, people are even misdiagnosed with type 2 diabetes when they really have type 1, making it harder to get the right treatment. Scientists have been working for years to better understand these risks, including the role of genes (see research on T1D genetics) and the immune system (learn more about T1D immunology).

How does the new AI-driven risk score work?

The new risk score, called a dynamic risk score (DRS), uses health AI to look at tiny molecules in the blood called microRNAs. These microRNAs can change in response to what is happening in the body, kind of like warning lights on a car dashboard. By studying these molecules in thousands of samples from people around the world, the scientists taught the AI to notice patterns linked to the start or progression of type 1 diabetes. This approach is different from earlier ones, which only checked risk at one moment in time. Instead, the DRS tracks changes over time, giving doctors a better idea of what might happen in the future (see the Nature Medicine study).

Why is dynamic monitoring better than one-time tests?

Most older tests for diabetes risk are like taking a single snapshot—they might miss important changes that happen later. The dynamic risk score works like a movie, watching for new signs as they appear. This means doctors can catch early warning signals before diabetes starts, or see if someone’s risk is going up or down. It also helps catch cases where someone was misdiagnosed, so they can get the right care sooner (read about misdiagnosis in diabetes). If doctors know someone is at higher risk, they can watch them more closely, and maybe even try treatments that could slow or stop diabetes from developing.

Personalized care and the future of health AI

One exciting thing about this new DRS is that it can help doctors personalize care. Not everyone with risk factors will get diabetes, so it’s important to know who needs extra help. The AI-driven score adapts as a person’s health changes, which could lead to better ways to prevent, treat, or even cure type 1 diabetes in some cases. This is a good example of how health AI is shaping research and medical care today. If you are curious about how health AI is being used while keeping patient privacy safe, you might enjoy this helpful summary: how health AI shapes research and privacy today.

What it means for patients and families

For families worried about type 1 diabetes, this new approach could mean fewer surprises and better health. Doctors might soon be able to spot problems early and avoid confusing type 1 with type 2 diabetes, especially in adults where mistakes happen often. It also means that treatments could be better matched to each person, instead of using a one-size-fits-all plan. Of course, as with any new technology, using health AI and sharing health data safely is important. If you want to learn simple steps to protect your health information, check out how to keep your health data private with AI.

Looking ahead: the promise and careful steps of health AI

As scientists continue to study how our genes, environment, and immune systems work together in diabetes (see this review of risk factors and the impact of environment on diabetes), new AI tools like the dynamic risk score could help people stay healthier for longer. These discoveries are showing us that with the help of health AI, we can not only understand diseases better, but also take smart steps to prevent them. With trusted sources like SlothMD sharing updates and advice, everyone can be part of this exciting future for medicine.

Comments

Health News

Jul 2, 2025

How chemotherapy changes blood stem cells over time

New studies reveal chemotherapy reduces blood stem cell diversity and causes genetic changes, with important health implications for cancer survivors.

Health News

Jul 2, 2025

How chemotherapy changes blood stem cells over time

New studies reveal chemotherapy reduces blood stem cell diversity and causes genetic changes, with important health implications for cancer survivors.

Health News

Jul 2, 2025

How chemotherapy changes blood stem cells over time

New studies reveal chemotherapy reduces blood stem cell diversity and causes genetic changes, with important health implications for cancer survivors.

Health Deep Dive

Jul 2, 2025

What congenital disorders of glycosylation mean for health

Explore congenital disorders of glycosylation, how they affect the body, the latest diagnostic advances, and what families need to know about these rare but important genetic conditions.

Health Deep Dive

Jul 2, 2025

What congenital disorders of glycosylation mean for health

Explore congenital disorders of glycosylation, how they affect the body, the latest diagnostic advances, and what families need to know about these rare but important genetic conditions.

Health Deep Dive

Jul 2, 2025

What congenital disorders of glycosylation mean for health

Explore congenital disorders of glycosylation, how they affect the body, the latest diagnostic advances, and what families need to know about these rare but important genetic conditions.

Health News

Jul 2, 2025

A new AI tool predicts type 1 diabetes risk

Scientists created an AI-powered risk score using microRNAs to better predict who might develop type 1 diabetes, helping doctors personalize care and avoid misdiagnosis.

Health News

Jul 2, 2025

A new AI tool predicts type 1 diabetes risk

Scientists created an AI-powered risk score using microRNAs to better predict who might develop type 1 diabetes, helping doctors personalize care and avoid misdiagnosis.

Health News

Jul 2, 2025

A new AI tool predicts type 1 diabetes risk

Scientists created an AI-powered risk score using microRNAs to better predict who might develop type 1 diabetes, helping doctors personalize care and avoid misdiagnosis.

©2025 — 360H, Inc.

*We are not affiliated, associated, or endorsed by any of the companies whose logos appear on this site. Their trademarks are the property of their respective owners, and any mention or depiction is solely for informational purposes.

©2025 — 360H, Inc.

*We are not affiliated, associated, or endorsed by any of the companies whose logos appear on this site. Their trademarks are the property of their respective owners, and any mention or depiction is solely for informational purposes.

SlothMD logo
SlothMD logo
SlothMD logo